Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterActive in the last 2 years

Mihnea Paul Dragomir

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5550-3516; OpenAlex author ID A5061270062. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
20
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 2 papers · 2026: 4 papers

Papers 9

  1. Spatial heterogeneity of antibody-drug conjugate targets in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/2056-4538.70083↗
  2. Identifying Factors of Organoid Establishment in Pancreatic Cancer: A Prospective Observational Study. Co-author DOI 10.1002/cam4.71490↗
  3. The basis for future personalized therapy approaches - Machine learning-generated 1-year survival rate, metastatic status and therapy-dependent survival in pan… Co-author DOI 10.1016/j.ejca.2025.116189↗
  4. Impact of culture dimensionality and matrix composition on morphology, phenotype and drug response in pancreatic cancer models. Co-author DOI 10.1038/s41598-026-47856-1↗
  5. DNA methylation profile to aid in the diagnosis of pancreatic ductal adenocarcinoma and its role in disease progression. Last author DOI 10.1080/17501911.2025.2554571↗
  6. Multi-drug pharmacotyping improves therapy prediction in pancreatic cancer organoids. Co-author DOI 10.1186/s12935-025-03969-7↗
  7. DNA methylation classifier to diagnose pancreatic ductal adenocarcinoma metastases from different anatomical sites. Last author DOI 10.1186/s13148-024-01768-x↗
  8. The Immune Checkpoint Landscape in Tumor Cells of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/ijms24032160↗
  9. Rethinking the TNM Classification Regarding Direct Lymph Node Invasion in Pancreatic Ductal Adenocarcinoma. First author DOI 10.3390/cancers14010201↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Marcus Bahra · 5 shared papers, 2024–2026 · strength 1.06
  2. Christopher Neumann · 5 shared papers, 2024–2026 · strength 1.06
  3. Uwe Pelzer · 5 shared papers, 2024–2026 · strength 1.06
  4. Matthäus Felsenstein · 4 shared papers, 2025–2026 · strength 0.90
  5. Simon Schallenberg · 4 shared papers, 2021–2026 · strength 0.74
  6. Katharina Wansch · 3 shared papers, 2025–2026 · strength 0.67
  7. Florian Dölvers · 3 shared papers, 2025–2026 · strength 0.67
  8. François Schneider · 3 shared papers, 2025–2026 · strength 0.67
  9. Teodor G. Calina · 2 shared papers, 2024–2025 · strength 0.58
  10. Elena Grafenhorst · 2 shared papers, 2024–2025 · strength 0.58
  11. Florian Nino Loch · 3 shared papers, 2021–2026 · strength 0.58
  12. Katharina Beyer · 2 shared papers, 2021–2023 · strength 0.30
  13. Carsten Kamphues · 2 shared papers, 2021–2023 · strength 0.30
  14. Frederick Klauschen · 1 shared paper, 2026 · strength 0.28
  15. Deema Sabtan · 1 shared paper, 2026 · strength 0.28
  16. Bruno Valentin Sinn · 1 shared paper, 2024 · strength 0.16
  17. George A. Călin · 1 shared paper, 2024 · strength 0.16
  18. Fiona Speichinger · 1 shared paper, 2021 · strength 0.12
  19. Ioannis Pozios · 1 shared paper, 2021 · strength 0.12
  20. Georgios Antonios Margonis · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.